Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological, and clinical overview
- 31 January 1992
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (1), 39-53
- https://doi.org/10.1016/0732-8893(92)90055-x
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycinDiagnostic Microbiology and Infectious Disease, 1992
- In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination againstLegionella speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Activity of new macrolides againstBordetella pertussis andBordetella parapertussisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Comparative antimicrobial activity of the new macrolides againstBorrelia burgdorferiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative in vitro activity of A-56268 against respiratory tract pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative in vitro activity of the new macroiide A-56268 against MycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria andChlamydia trachomatisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibioticEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987